Poll: Will you be attending COPHy in Lisbon, Portugal, from March 24 to 25?

Poll
Conference|COPHy

A poll for retina specialists: Let us know if you will attend the 14th annual Congress on Controversies in Ophthalmology.

Will you be attending COPHy in Lisbon, Portugal, from March 24 to 25?

Yes
No

Newsletter

Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.

Subscribe Now!
Recent Videos
Victor Gonzalez, MD, speaks about his Clinical Trials at the Summit presentation, focusing on retinitis pigmentosa therapy MCO-010 (Nanoscope Therapeutics)
Related Content
The popular game "Guess Who?" with cards flipped up to reveal dozens of faces. Concept image for EURETINA schedule and editorial advisory board member presentations. Image credit: ©Milos – stock.adobe.com

Don't miss our editorial board at the 2025 EURETINA Congress

Hattie Hayes
August 28th 2025
Article
Integrating AI to manage DR in a primary care setting

Integrating AI to manage DR in a primary care setting

Alex Delaney-Gesing ;David Hutton
August 28th 2025
Podcast
Le Palais des Congrès (pictured), where the European Society of Retina Specialists (EURETINA) will hold its 2025 meeting. Image credit: ©zefart – stock.adobe.com

EURETINA marks a milestone with 25th annual Congress

Hattie Hayes
August 28th 2025
Article
What to expect from virtual AAO 2020

What to expect from virtual AAO 2020

Alex Delaney-Gesing
August 28th 2025
Podcast
Q&A: Danny A. Mammo, MD, on the associations between androgen exposure, PCOS, and transmasculine individuals with central serous chorioretinopathy

Q&A: Danny A. Mammo, MD, on the associations between androgen exposure, PCOS, and transmasculine individuals with central serous chorioretinopathy

Danny A. Mammo, MD;Martin David Harp;Sydney M Crago
August 28th 2025
Article
Q&A: Andrew J. Barkmeier, MD, on the risk of sight-threatening diabetic retinopathy with GLP-1 RA use

Q&A: Andrew J. Barkmeier, MD, on the risk of sight-threatening diabetic retinopathy with GLP-1 RA use

Andrew J. Barkmeier, MD;Sydney M Crago;Martin David Harp
August 28th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.